Nature de la demande
Réévaluation du SMR
Service Médical Rendu (SMR)
| Faible |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
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
uM9vE82WHyZj5yra
